Search results
May 8, 2024 · Pharmaniaga Bhd’s (KL:PHARMA) has been flagged by its independent auditors again, as its current deficit and capital deficiency for the financial year ended Dec 31, 2023 (FY2023) widened from a year ago. Messrs PricewaterhouseCoopers PLT (PwC) raised material uncertainty on the Pharmaniaga whereby its audit indicated that the group and the company incurred net losses of RM78.7 million and ...
Username. Password. In case of forgotten Password/Username, please contact our Customer Care Toll Free Line
CEO: Behind the scenes at Pharmaniaga. By GANESHWARAN KANA. Corporate News. Saturday, 04 Mar 2023. “The provision of RM552mil was made for 14 million doses of the Sinovac vaccine. We are talking ...
PHARMANIAGA SOARS IN Q1 FY2024, PAT SURGES 10-FOLD. 10 MAY 2024. PHARMANIAGA CONFIDENT OF FINANCIAL RECOVERY, FUELLED BY ROBUST BUSINESS FUNDAMENTALS AND SOLID STRATEGIES. 29 FEBRUARY 2024. PHARMANIAGA FORTIFIES LEADERSHIP, APPOINTS ZULKIFLI JAFAR AS EXECUTIVE DIRECTOR TO DRIVE THE COMPANY’S TURNAROUND. 23 FEBRUARY 2024.
Established in 1994, Pharmaniaga has evolved to become one of Malaysia’s largest listed integrated pharmaceutical groups. Our participation in the sector spans across the pharmaceutical value chain from research and development to the production of generic drugs, over-the-counter medicines, logistics and distribution, sales and marketing. In ...
Feb 23, 2024 · Pharmaniaga, alongside a private placement aimed at drawing potential strategic investors to contribute to the Group’s value enhancement and growth in the healthcare sector. Supporting this strategic initiative, the Group’s substantial shareholders, Lembaga Tabung Angkatan Tentera (LTAT) and Boustead Holdings Berhad (BHB) have
May 18, 2023 · Pharmaniaga said despite facing recent challenges and being classified under Practice Note 17 (PN17), its Q1 results showcased resilience and strategic agility. The positive results provide renewed momentum for Pharmaniaga and pave a promising path for its performance in the upcoming quarters of 2023. During the review period, its logistics and ...
